Woolson Daniel, VP and GM of Infusion Capital at ICU Medical ($ICUI), made one open market sale of common shares in the last year, totaling $441 thousand. His most recent sale occurred on November 25, 2025. With no open market purchases recorded, his sales rank 6,748th out of nearly 12,000 insiders, below the average of $8.6 million per seller across 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 2924 | $0.00 | 25,897.0000 | 24,904,000 | 12.73% | 0.01% |
| March 15, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 1295 | $125.85 | 24,602.0000 | 24,904,000 | 5.00% | 0.01% |
| March 15, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Performance Shares | 2924 | $0.00 | 0.0000 | 24,904,000 | 100.00% | 0.01% |
| March 7, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Performance Shares | 1585 | $0.00 | 3,170.0000 | 24,904,000 | 33.33% | 0.01% |
| March 7, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 1585 | $0.00 | 12,882.0000 | 24,904,000 | 14.03% | 0.01% |
| March 7, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 702 | $132.00 | 12,180.0000 | 24,904,000 | 5.45% | 0.00% |
| March 8, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 16147 | $0.00 | 28,327.0000 | 24,904,000 | 132.57% | 0.06% |
| March 8, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 6877 | $132.00 | 21,450.0000 | 24,904,000 | 24.28% | 0.03% |
| March 8, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 2153 | $0.00 | 23,603.0000 | 24,904,000 | 10.04% | 0.01% |
| March 8, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 630 | $132.00 | 22,973.0000 | 24,904,000 | 2.67% | 0.00% |
| March 8, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 2153 | $0.00 | 6,908.0000 | 24,904,000 | 23.76% | 0.01% |
| March 8, 2026 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Performance Shares | 16147 | $0.00 | 0.0000 | 24,904,000 | 100.00% | 0.06% |
| Nov. 25, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | S | Common Stock | 2897 | $152.35 | 11,297.0000 | 24,783,000 | 20.41% | 0.01% |
| March 15, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Performance Shares | 2923 | $0.00 | 2,924.0000 | 24,388,000 | 49.99% | 0.01% |
| March 15, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 1294 | $143.45 | 14,194.0000 | 24,388,000 | 8.35% | 0.01% |
| March 15, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 2923 | $0.00 | 15,488.0000 | 24,388,000 | 23.26% | 0.01% |
| March 8, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 2153 | $0.00 | 9,061.0000 | 24,388,000 | 19.20% | 0.01% |
| March 7, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 966 | $0.00 | 11,832.0000 | 24,388,000 | 8.89% | 0.00% |
| March 7, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 467 | $141.97 | 11,365.0000 | 24,388,000 | 3.95% | 0.00% |
| March 8, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 2153 | $0.00 | 13,518.0000 | 24,388,000 | 18.94% | 0.01% |
| March 8, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 953 | $141.97 | 12,565.0000 | 24,388,000 | 7.05% | 0.00% |
| March 7, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 966 | $0.00 | 0.0000 | 24,388,000 | 100.00% | 0.00% |
| March 7, 2025 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | A | Common Stock | 4755 | $0.00 | 11,214.0000 | 24,388,000 | 73.62% | 0.02% |
| Dec. 6, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | S | Common Stock | 2241 | $156.25 | 10,866.0000 | 24,438,000 | 17.10% | 0.01% |
| Aug. 30, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | S | Common Stock | 2502 | $163.22 | 13,107.0000 | 24,091,000 | 16.03% | 0.01% |
| March 15, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Performance Shares | 2923 | $0.00 | 5,847.0000 | 24,091,000 | 33.33% | 0.01% |
| March 15, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 1294 | $98.08 | 15,609.0000 | 24,091,000 | 7.66% | 0.01% |
| March 15, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 2923 | $0.00 | 16,903.0000 | 24,091,000 | 20.91% | 0.01% |
| March 15, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | S | Common Stock | 791 | $98.27 | 13,980.0000 | 24,091,000 | 5.36% | 0.00% |
| March 7, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 966 | $0.00 | 10,843.0000 | 24,091,000 | 9.78% | 0.00% |
| March 7, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 426 | $105.39 | 10,417.0000 | 24,091,000 | 3.93% | 0.00% |
| March 7, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 5792 | $0.00 | 16,209.0000 | 24,091,000 | 55.60% | 0.02% |
| March 8, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 2020 | $0.00 | 15,665.0000 | 24,091,000 | 14.80% | 0.01% |
| March 7, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 2564 | $105.39 | 13,645.0000 | 24,091,000 | 15.82% | 0.01% |
| March 8, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | F | Common Stock | 894 | $104.52 | 14,771.0000 | 24,091,000 | 5.71% | 0.00% |
| March 7, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Common Stock | 966 | $0.00 | 966.0000 | 24,091,000 | 50.00% | 0.00% |
| March 8, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | A | Common Stock | 6459 | $0.00 | 6,459.0000 | 24,091,000 | 9999.99% | 0.03% |
| March 7, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Performance Shares | 5792 | $0.00 | 0.0000 | 24,091,000 | 100.00% | 0.02% |
| March 8, 2024 | ICU MEDICAL INC/DE | $ICUI | Woolson Daniel | VP, GM-Infusion Capital | M | Performance Shares | 2020 | $0.00 | 0.0000 | 24,091,000 | 100.00% | 0.01% |